Hepatitis is a serious disease that is primarily characterized by the inflammation and damaging of the liver. Hundreds and millions of people all over the world suffer from the three different types of this disease, namely hepatitis A, B, and C.

Some people are unaware of the deadly after effects of being infected by Hepatitis C virus or how the disease is transmitted. The most important question that comes to everyone’s mind – Is Hepatitis C contagious or not?

Hepatitis C also known as hep C is an infection which is caused by a virus that attacks the liver of the human beings and leads to the inflammation of the liver.

Throughout one’s life, bone tissues break down and build up again; this well-balanced process is called bone remodeling. The balance, however, tilts when women hit menopause and estrogen levels go down as estrogen plays a significant part in the process of remodeling bones.

Hepatitis C is a viral infection that severely damages the liver over time and leads to scarring. This disease progresses in four stages and starts with mild inflammation while finally resulting in severe liver damage or cirrhosis.

Hepatitis C is a disease caused due to an infection by Hepatitis C virus that affects the liver. This health disorder has two different phases – acute and chronic. An individual having the former phase means he or she got affected recently while the latter phase means a person has the infection for over six months.

Cancer cells are those cells in our body that do not function as they are supposed to. When they change, grow and multiply out of control, they cease to be normal within our body.

Nivolumab drug is a fully humanized, monoclonal, immunoglobulin antibody, with which clinical trials are being undertaken for the treatment of various types of cancer. Each Nivolumab clinical trial is conducted by the US National Institute of Health and is supported by the government to help find answers to cancer treatment.